Filter
3403
Filtered Results: 3403
Text search:
health
facility
survey
Featured
Recommendations
249
New Publications
1200
Language
Document type
No document type
2233
Studies & Reports
504
Guidelines
324
Strategic & Response Plan
129
Manuals
122
Training Material
31
Fact sheets
26
Situation Updates
20
Resource Platforms
5
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Kenya
182
India
172
Ethiopia
140
Nepal
134
Nigeria
106
Uganda
104
Malawi
102
Sierra Leone
95
Rwanda
92
Global
90
Liberia
85
Zambia
81
Tanzania
73
Ghana
72
South Africa
72
Bangladesh
71
Myanmar / Burma
63
Namibia
53
Africa
46
Philippines
38
Cambodia
37
Western and Central Europe
36
Lesotho
35
Latin America and the Carribbean
35
Congo, Democratic Republic of
34
Syria
34
Zimbabwe
33
Ukraine
33
Senegal
32
Botswana
28
Indonesia
27
Mozambique
26
Asia
23
Eastern Europe
23
South Sudan
20
Haiti
19
Burkina Faso
18
Cameroon
18
South–East Asia Region
18
East and Southern Africa
17
Pakistan
16
Afghanistan
15
Benin
15
Eswatini/ Swaziland
15
Guinea
13
West and Central Africa
12
Russia
11
Middle East and North Africa
10
Yemen
9
Mali
8
Germany
8
Jordan
7
Lebanon
7
Central African Republic
7
Sudan
6
Brazil
6
Laos
6
Somalia
5
Madagascar
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Venezuela
5
Vietnam
5
Turkey
4
Papua New Guinea
4
Burundi
4
Sri Lanka
4
Tajikistan
4
Moldova
4
Iraq
3
Mexico
3
Palestine
3
Albania
3
Southern Africa
3
Timor Leste/ East Timor
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Niger
2
Thailand
2
Gambia
2
China
2
Colombia
2
Ecuador
2
Angola
2
Guatemala
2
Paraguay
2
Bhutan
2
Georgia
2
Turkmenistan
2
France
2
Mauritius
2
Egypt
1
Ireland
1
Singapore
1
Argentina
1
Peru
1
North Macedonia
1
Serbia
1
Bolivia
1
Greece
1
Other region
1
Fiji
1
Poland
1
Mongolia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Lithuania
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
North America
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1915
Clinical Guidelines
187
Women & Child Health
162
Public Health
146
Key Resources
144
Capacity Building
51
Pharmacy & Technologies
17
Toolboxes
HIV
241
COVID-19
207
TB
181
Mental Health
127
AMR
118
Disability
102
Caregiver
94
Conflict
77
Ebola
67
Planetary Health
63
Pharmacy
49
NTDs
48
Rapid Response
47
NCDs
44
Refugee
29
Global Health Education
28
Natural Hazards
25
Polio
21
Health Financing Toolbox
20
Cholera
13
Specific Hazards
10
Zika
6
Social Ethics
4
Typhoon
2
Accessed Febr. 6, 2020
accessed Febr. 6, 2020
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reac...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the ach...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empir...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through...
This report presents an assessment of the institutional readiness to detect, prevent and address health issues associated with ASGM and aims to provide an input to the Ministry of Health (MISAU) to ...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). I...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
